Palliative management of gastric cancer

Surgical Oncology

Volumn 16, Issue 4, 2007, Pages 267-275

  Cunningham, Steven C ^a,b   Schulick, Richard D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Gastric cancer; Palliation

Indexed keywords

CISPLATIN; DOCETAXEL; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; PACLITAXEL; TUMOR MARKER;

AWARENESS; BYPASS SURGERY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FECES; GASTROINTESTINAL ENDOSCOPY; HUMAN; MEDICAL EDUCATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SERUM; STENT; STOMACH ADENOCARCINOMA; TREATMENT INDICATION;

ADENOCARCINOMA; GASTROSCOPY; HUMANS; MASS SCREENING; NEOPLASM STAGING; PALLIATIVE CARE; PROGNOSIS; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36549074089     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2007.08.004     Document Type: Review

References (99)

1. Rothschild B.M., Tanke D.H., Helbling II M., and Martin L.D. Epidemiologic study of tumors in dinosaurs. Naturwissenschaften 90 (2003) 495-500
2. Rothschild B.M., Witzke B.J., and Hershkovitz I. Metastatic cancer in the Jurassic. Lancet 354 (1999) 398
3. Santoro E. The history of gastric cancer: legends and chronicles. Gastric Cancer 8 (2005) 71-74
4. History SC. Cancer: a historic perspective: 2006 vol. US National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program; 2006.
5. Simpson J. Oxford English dictionary. 3rd ed. In: Simpson J. (Ed) (2006), Oxford University Press, Oxford
6. Weil P.H., and Buchberger R. From Billroth to PCV: a century of gastric surgery. The World Journal of Surgery 23 (1999) 736-742
7. Pisani P., Parkin D.M., Bray F., and Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. International Journal of Cancer 83 (1999) 18-29
8. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA: A Cancer Journal for Clinicians 56 (2006) 106-130
9. Crew K.D., and Neugut A.I. Epidemiology of gastric cancer. World Journal of Gastroenterology 12 (2006) 354-362
10. Cunningham S.C., Kamangar F., Kim M.P., et al. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. Journal of Gastrointestinal Surgery 9 (2005) 718-725
11. Hallissey M.T., Allum W.H., Roginski C., and Fielding J.W. Palliative surgery for gastric cancer. Cancer 62 (1988) 440-444
12. Nash C.L., and Gerdes H. Methods of palliation of esophageal and gastric cancer. Surgical Oncology Clinics of North America 11 (2002) 459-483 xiii
13. Wanebo H.J., Kennedy B.J., Chmiel J., Steele Jr. G., Winchester D., and Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Annals of Surgery 218 (1993) 583-592
14. Allum W.H., Powell D.J., McConkey C.C., and Fielding J.W. Gastric cancer: a 25-year review. British Journal of Surgery 76 (1989) 535-540
15. Miner T.J. Palliative surgery for advanced cancer: lessons learned in patient selection and outcome assessment. American Journal of Clinical Oncology 28 (2005) 411-414
16. Miner T.J., Brennan M.F., and Jaques D.P. A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer. Annals of Surgery 240 (2004) 719-726 [discussion 726-7]
17. Miner T.J., Jaques D.P., Tavaf-Motamen H., and Shriver C.D. Decision making on surgical palliation based on patient outcome data. American Journal of Surgery 177 (1999) 150-154
18. McCahill L.E., Dunn G.P., Mosenthal A.C., Milch R.A., and Krouse R.S. Palliation as a core surgical principle: part 1. The Journal of American College of Surgeons 199 (2004) 149-160
19. Palliation as a core surgical principle: part 2. The Journal of American College of Surgeons 2004;199:321-34.
20. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual (2002), Springer, New York
21. Fleming I.D. AJCC cancer staging handbook: for the AJCC cancer staging manual. 5th ed. (1998), Lippencott, Williams, & Wilkens, New York
22. Geramizadeh B., Shafiee A., Saberfirruzi M., Kumar P.K., and Shaheem A. Brush cytology of gastric malignancies. Acta Cytologica 46 (2002) 693-696
23. Ito S., Muguruma N., Kimura T., et al. Principle and clinical usefulness of the infrared fluorescence endoscopy. The Journal of Medical Investigation 53 (2006) 1-8
24. Moreto M. Diagnosis of esophagogastric tumors. Endoscopy 37 (2005) 26-32
25. Gretschel S., Moesta K.T., Hunerbein M., et al. New concepts of staging in gastrointestinal tumors as a basis of diagnosis and multimodal therapy. Onkologie 27 (2004) 23-30
26. Chen C.H., Yang C.C., and Yeh Y.H. Preoperative staging of gastric cancer by endoscopic ultrasound: the prognostic usefulness of ascites detected by endoscopic ultrasound. Journal of Clinical Gastroenterology 35 (2002) 321-327
27. Potrc S., Skalicky M., and Ivanecz A. Does endoscopic ultrasound staging already allow individual treatment regimens in gastric cancer. Wiener Klinische Wochenschrift 118 Suppl. 2 (2006) 48-51
28. Tsendsuren T., Jun S.M., and Mian X.H. Usefulness of endoscopic ultrasonography in preoperative TNM staging of gastric cancer. World Journal of Gastroenterology 12 (2006) 43-47
29. Davies J., Chalmers A.G., Sue-Ling H.M., et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging. Gut 41 (1997) 314-319
30. Fukuya T., Honda H., Kaneko K., et al. Efficacy of helical CT in T-staging of gastric cancer. Journal of Computer Assisted Tomography 21 (1997) 73-81
31. Lim J.S., Yun M.J., Kim M.J., et al. CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics 26 (2006) 143-156
32. Miner T.J., Jaques D.P., and Shriver C.D. A prospective evaluation of patients undergoing surgery for the palliation of an advanced malignancy. Annals of Surgical Oncology 9 (2002) 696-703
33. Miner T.J., Jaques D.P., Karpeh M.S., and Brennan M.F. Defining palliative surgery in patients receiving noncurative resections for gastric cancer. The Journal of American College of Surgeons 198 (2004) 1013-1021
34. McCahill L.E., Krouse R., Chu D., et al. Indications and use of palliative surgery-results of Society of Surgical Oncology survey. Annals of Surgical Oncology 9 (2002) 104-112
35. Sugarbaker P.H., and Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 58 (2000) 96-107
36. Sugarbaker P.H., and Yonemura Y. Palliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology 48 (2001) 1238-1247
37. Sugarbaker P.H., Yu W., and Yonemura Y. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Seminars in Surgical Oncology 21 (2003) 233-248
38. Saidi R.F., ReMine S.G., Dudrick P.S., and Hanna N.N. Is there a role for palliative gastrectomy in patients with stage IV gastric cancer?. World Journal of Surgery 30 (2006) 21-27
39. Petry J.J. Surgery and meaning. Surgery 127 (2000) 363-365
40. Lawrence W., and McNeer G. The effectiveness of surgery for palliation of incurable gastric cancer. Cancer 11 (1958) 28-32
41. ReMine W.H. Palliative operations for incurable gastric cancer. World Journal of Surgery 3 (1979) 721-729
42. Meijer S., De Bakker O.J., and Hoitsma H.F. Palliative resection in gastric cancer. Journal of Surgical Oncology 23 (1983) 77-80
43. Medina-Franco H., Contreras-Saldivar A., Ramos-De La Medina A., Palacios-Sanchez P., Cortes-Gonzalez R., and Ugarte J.A. Surgery for stage IV gastric cancer. American Journal of Surgery 187 (2004) 543-546
44. Samarasam I., Chandran B.S., Sitaram V., Perakath B., Nair A., and Mathew G. Palliative gastrectomy in advanced gastric cancer: is it worthwhile?. ANZ Journal of Surgery 76 (2006) 60-63
45. Ouchi K., Sugawara T., Ono H., et al. Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. Journal of Surgical Oncology 69 (1998) 41-44
46. Hartgrink H.H., Putter H., Klein Kranenbarg E., Bonenkamp J.J., and van de Velde C.J. Value of palliative resection in gastric cancer. British Journal of Surgery 89 (2002) 1438-1443
47. Kahlke V., Bestmann B., Schmid A., Doniec J.M., Kuchler T., and Kremer B. Palliation of metastatic gastric cancer: impact of preoperative symptoms and the type of operation on survival and quality of life. World Journal of Surgery 28 (2004) 369-375
48. Choi Y.B. Laparoscopic gatrojejunostomy for palliation of gastric outlet obstruction in unresectable gastric cancer. Surgical Endoscopy 16 (2002) 1620-1626
49. Fiori E., Lamazza A., Volpino P., et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Research 24 (2004) 269-271
50. Truong S., Bohndorf V., Geller H., Schumpelick V., and Gunther R.W. Self-expanding metal stents for palliation of malignant gastric outlet obstruction. Endoscopy 24 (1992) 433-435
51. Dormann A., Meisner S., Verin N., and Wenk Lang A. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 36 (2004) 543-550
52. Leong T. Chemotherapy and radiotherapy in the management of gastric cancer. Current Opinion in Gastroenterology 21 (2005) 673-678
53. Varadhachary G., and Ajani J.A. Gastric cancer. Clinical Advances in Hematology and Oncology 3 (2005) 118-124
54. Wagner A.D., Grothe W., Haerting J., Kleber G., Grothey A., and Fleig W.E. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. Journal of Clinical Oncology 24 (2006) 2903-2909
55. Murad A.M., Santiago F.F., Petroianu A., Rocha P.R., Rodrigues M.A., and Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 72 (1993) 37-41
56. Glimelius B., Ekstrom K., Hoffman K., et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Annals of Oncology 8 (1997) 163-168
57. Pyrhonen S., Kuitunen T., Nyandoto P., and Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. British Journal of Cancer 71 (1995) 587-591
58. Ilson D.H. Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead?. Journal of Clinical Oncology 20 (2002) 1962-1964
59. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine 355 (2006) 11-20
60. Brenner B, Shah MA, Karpeh MS, et al. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Annals of Oncology 2006.
61. Yonemura Y., Bandou E., Sawa T., et al. Neoadjuvant treatment of gastric cancer with peritoneal dissemination. European Journal of Surgical Oncology 32 (2006) 661-665
62. Newman E., Potmesil M., Ryan T., et al. Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study. Seminars in Oncology 32 (2005) S97-S100
63. Farma J.M., Pingpank J.F., Libutti S.K., et al. Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion. Journal of Gastrointestinal Surgery 9 (2005) 1346-1353
64. Xu D.Z., Zhan Y.Q., Sun X.W., Cao S.M., and Geng Q.R. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World Journal of Gastroenterology 10 (2004) 2727-2730
65. Hall J.J., Loggie B.W., Shen P., et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. Journal of Gastrointestinal Surgery 8 (2004) 454-463
66. Glehen O., Schreiber V., Cotte E., et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Archives of Surgery 139 (2004) 20-26
67. Glehen O., Mohamed F., and Gilly F.N. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. The Lancet Oncology 5 (2004) 219-228
68. Yu W. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy. European Journal of Surgical Oncology 32 (2006) 655-660
69. Cunningham S.C., Kamangar F., Kim M.P., et al. Claudin-4, Mkk4, and Stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiology, Biomarkers, and Prevention 15 (2006) 281-287
70. Qiao S.X., Yuan M., Liu Y.L., Lin X.S., Zhang X.P., and Tobi M. Detection of gastric cancer and premalignant lesions by novel marker glycoprotein 87 using monoclonal antibody Adnab-9. Cancer Epidemiology Biomarkers and Prevention 12 (2003) 1095-1099
71. Mirza Z.K., Das K.K., Slate J., et al. Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma. Gut 52 (2003) 807-812
72. Grotzinger C., Kneifel J., Patschan D., et al. LI-cadherin: a marker of gastric metaplasia and neoplasia. Gut 49 (2001) 73-81
73. Hardt P.D., Toepler M., Ngoumou B., Rupp J., and Kloer H.U. Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening. Anticancer Research 23 (2003) 855-857
74. Kim Y., Lee S., Park S., et al. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. Annals of Clinical and Laboratory Science 33 (2003) 32-38
75. Xin W., Yun K.J., Ricci F., et al. MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course. Clinical Cancer Research 10 (2004) 8516-8520
76. Cunningham SC, Kamangar F, Kim MP, et al. Mkk4 status predicts survival after resection of gastric adenocarcinoma. Archives of Surgery 2006; 141(11): 1095-9; discussion 1100.
77. Teng D.H., Perry III W.L., Hogan J.K., et al. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Research 57 (1997) 4177-4182
78. Su G.H., Hilgers W., Shekher M.C., et al. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Research 58 (1998) 2339-2342
79. Parsons D.W., Wang T.L., Samuels Y., et al. Colorectal cancer: mutations in a signalling pathway. Nature 436 (2005) 792
80. McCahill L.E., Dunn G.P., Mosenthal A.C., Milch R.A., and Krouse R.S. Palliation as a core surgical principle: part 2. The Journal of American College of Surgeons 199 (2004) 321-334
81. Cady B., Easson A., Aboulafia A.J., and Ferson P.F. Part 1: Surgical palliation of advanced illness-what's new, what's helpful. The Journal of American College of Surgeons 200 (2005) 115-127
82. Cady B., Miner T., and Morgentaler A. Part 2: Surgical palliation of advanced illness-what's new, what's helpful. The Journal of American College of Surgeons 200 (2005) 281-290
83. Cady B., Barker F., Easson A., et al. Part 3: Surgical palliation of advanced illness-what's new, what's helpful. The Journal of American College of Surgeons 200 (2005) 457-466
84. Simpson D.E. Curriculum innovations from The Robert Wood Johnson National End-of-Life Residency Education Training Project. Journal of Palliative Medicine 5 (2002) 915
85. Weissman D.E., Mullan P., Ambuel B., et al. National Residency End-of-Life Education Project: project abstracts and progress reports. Journal of Palliative Medicine 8 (2005) 646-664
86. Monson J.R., Donohue J.H., McIlrath D.C., Farnell M.B., and Ilstrup D.M. Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer 68 (1991) 1863-1868
87. Kim J.H., Yoo B.M., Lee K.J., et al. Self-expanding coil stent with a long delivery system for palliation of unresectable malignant gastric outlet obstruction: a prospective study. Endoscopy 33 (2001) 838-842
88. Adler D.G., and Baron T.H. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. American Journal of Gastroenterology 97 (2002) 72-78
89. Mittal A., Windsor J., Woodfield J., Casey P., and Lane M. Matched study of three methods for palliation of malignant pyloroduodenal obstruction. British Journal of Surgery 91 (2004) 205-209
90. Jeong J.Y., Kim Y.J., Han J.K., et al. Palliation of anastomotic obstructions in recurrent gastric carcinoma with the use of covered metallic stents: clinical results in 25 patients. Surgery 135 (2004) 171-177
91. Mosler P., Mergener K.D., Brandabur J.J., Schembre D.B., and Kozarek R.A. Palliation of gastric outlet obstruction and proximal small bowel obstruction with self-expandable metal stents: a single center series. Journal of Clinical Gastroenterology 39 (2005) 124-128
92. Thuss-Patience P.C., Kretzschmar A., Repp M., et al. Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study. Journal of Clinical Oncology 23 (2005) 494-501
93. Moehler M., Eimermacher A., Siebler J., et al. Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer. British Journal of Cancer 92 (2005) 2122-2128
94. Park S.H., Lee W.K., Chung M., et al. Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil. Anticancer Drugs 17 (2006) 225-229
95. Moreno-Otero R., Marron C., Cantero J., Pajares J.M., and Martinez-Raposo A. Endoscopic biopsy and cytology in the diagnosis of malignant gastric ulcers. Diagnostic Cytopathology 5 4 (1989) 366-370
96. Jorde R., Ostensen H., Bostad L.H., Burhol P.G., and Langmark F.T. Cancer detection in biopsy specimens taken from different types of gastric lesions. Cancer 58 2 (1986) 376-382
97. Kurihara M., Shirakabe H., Yarita T., Izumi T., Miyasaka K., Maruyama T., and Kobayashi S. Diagnosis of small early gastric cancer by X-ray, endoscopy, and biopsy. Cancer Detection Prevention 4 1-4 (1981) 377-383
98. Kurtz R.C., and Sherlock P. The diagnosis of gastric cancer. Seminars in Oncology 12 1 (1985) 11-18
99. Graham D.Y., Schwartz J.T., Cain G.D., and Gyorkey F. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology 82 2 (1982) 228-231